Boundless Bio

About:

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Website: https://boundlessbio.com

Twitter/X: BoundlessBio

Top Investors: Fidelity, ARCH Venture Partners, RA Capital Management, Wellington Management, Vertex Ventures

Description:

Boundless Bio is a company that develops novel cancer therapeutics intended to understand and treat untraceable cancers. It aims to be the biopharma company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable cancers.

Total Funding Amount:

$251M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)boundlessbio.com

Founders:

Benjamin Cravatt, Howard Chang, Jonathan Lim, Keith Lenden

Number of Employees:

101-250

Last Funding Date:

2023-05-16

IPO Status:

Public

Industries:

© 2025 bioDAO.ai